Response of preclinical medulloblastoma models to combination therapy with 13-cis retinoic acid and suberoylanilide hydroxamic acid (SAHA) (original) (raw)
McNeil DE, Cote TR, Clegg L, Rorke LB (2002) Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Med Pediatr Oncol 39:190–194 ArticlePubMed Google Scholar
Gilbertson RJ (2004) Medulloblastoma: signalling a change in treatment. Lancet Oncol 5:209–218 ArticlePubMed Google Scholar
Geyer JR, Sposto R, Jennings M et al (2005) Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children’s Cancer Group. J Clin Oncol 23:7621–7631 ArticlePubMed Google Scholar
Silber JH, Radcliffe J, Peckham V et al (1992) Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score. J Clin Oncol 10:1390–1396 PubMedCAS Google Scholar
Hoppe-Hirsch E, Renier D, Lellouch-Tubiana A, Sainte-Rose C, Pierre-Kahn A, Hirsch JF (1990) Medulloblastoma in childhood: progressive intellectual deterioration. Childs Nerv Syst 6:60–65 ArticlePubMedCAS Google Scholar
Ris MD, Packer R, Goldwein J, Jones-Wallace D, Boyett JM (2001) Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children’s Cancer Group study. J Clin Oncol 19:3470–3476 PubMedCAS Google Scholar
Copeland DR, deMoor C, Moore BD, Ater JL (1999) Neurocognitive development of children after a cerebellar tumor in infancy: a longitudinal study. J Clin Oncol 17:3476–3486 PubMedCAS Google Scholar
Xu W, Janss A, Packer RJ, Phillips P, Goldwein J, Moshang T (2004) Endocrine outcome in children with medulloblastoma treated with 18 Gy of craniospinal radiation therapy. Neuro-Oncology 6:113–118 ArticlePubMed Google Scholar
Ranke MB, Price DA, Lindberg A, Wilton P, Darendeliler F, Reiter EO (2005) Final height in children with medulloblastoma treated with growth hormone. Horm Res 64:28–34 ArticlePubMedCAS Google Scholar
Knight KRG, Kraemer DF, Neuwelt EA (2005) Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development. J Clin Oncol 23:8588–8596 ArticlePubMed Google Scholar
Miller WH (1998) The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 83:1471–1482 ArticlePubMedCAS Google Scholar
Hallahan AR, Pritchard JI, Chandraratna RA et al (2003) BMP-2 mediates retinoid-induced apoptosis in medulloblastoma cells through a paracrine effect. Nat Med 9:1033–1038 ArticlePubMedCAS Google Scholar
Spiller SE, Ravanpay AC, Hahn AW, Olson JM (2006) Suberoylanilide hydroxamic acid is effective in preclinical studies of medulloblastoma. J Neurooncol 79:259–270 ArticlePubMedCAS Google Scholar
Chinnaiyan P, Vallabhaneni G, Armstrong E, Huang SM, Harari PM (2005) Modulation of radiation response by histone deacetylase inhibition. Int J Radiat Oncol Biol Phys 62:223–229 ArticlePubMedCAS Google Scholar
Sonnemann J, Kumar KS, Heesch S et al (2006) Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells. Int J Oncol 28:755–766 PubMedCAS Google Scholar
Hallahan AR, Pritchard JI, Hansen S et al (2004) The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res 64:7794–7800 ArticlePubMedCAS Google Scholar
Khan AA, Villablanca JG, Reynolds CP, Avramis VI (1996) Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation. Cancer Chemother Pharmacol 39:34–41 ArticlePubMedCAS Google Scholar
Freemantle SJ, Spinella MJ, Dmitrovsky E (2003) Retinoids in cancer therapy and chemoprevention: promise meets resistance. Oncogene 22:7305–7315 ArticlePubMedCAS Google Scholar
Henderson C, Mizzau M, Paroni G, Maestro R, Schneider C, Brancolini (2003) Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin–A (TSA) and suberoylanilide hydroxamic acid (SAHA). J Biol Chem 278(14):12579–12589 ArticlePubMedCAS Google Scholar
Shao Y, Gao Z, Marks PA, Jiang X (2004) Apoptotic and autophagic cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci U S A 101:18030–18035 ArticlePubMedCAS Google Scholar
Coffey DC, Kutko MC, Glick RD et al (2001) The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid. Cancer Res 61:3591–3594 PubMedCAS Google Scholar
Wang X, Qian DZ, Ren M et al (2005) Epigenetic modulation of retinoic acid receptor β2 by the histone deacetylase inhibitor MS-275 in human renal cell carcinoma. Clin Cancer Res 11:3535–3542 ArticlePubMedCAS Google Scholar
Touma SE, Goldberg JS, Moench P et al (2005) Retinoic acid and the histone deacetylase inhibitor trichostatin A inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model. Clin Cancer Res 11:3558–3566 ArticlePubMedCAS Google Scholar
Ferrara FF, Fazi F, Bianchini A et al (2001) Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. Cancer Res 61:2–7 PubMed Google Scholar
Demary K, Wond L, Spanjaard RA (2001) Effects of retinoic acid and sodium butyrate on gene expression, histone acetylation and inhibition of proliferation of melanoma cells. Cancer Lett 163:103–108 ArticlePubMedCAS Google Scholar
Packer RJ, Goldwin J, Nicholson HS et al (1999) Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children’s Cancer Group study. J Clin Oncol 17(7):2127–2136 PubMedCAS Google Scholar
Aebi S, Kroning R, Cenni B et al (1999) All-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cells. Clin Cancer Res 3:2033–2038 Google Scholar
Kim MS, Blake M, Baek JH, Kohlhagen G, Pommier Y, Carrier F (2003) Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. Cancer Res 63:7291–7300 PubMedCAS Google Scholar
Sato T, Suzuki M, Sato Y, Echigo S, Rikiishi H (2006) Sequence-dependent interaction between cisplatin and histone deacetylase inhibitors in human oral squamous cell carcinoma cells. Int J Oncol 28:1233–1241 PubMedCAS Google Scholar
Pilatrino C, Cilloni D, Messa E et al (2005) Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid. Cancer 104:101–109 ArticlePubMedCAS Google Scholar
Kuendgen A, Strupp C, Alvado M et al (2004) Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid. Blood 104:1266–1269 ArticlePubMedCAS Google Scholar
Bug G, Ritter M, Wassmann B et al (2005) Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia. Cancer 104:2717–2725 ArticlePubMedCAS Google Scholar